Evotec SE (EVO) Net Cash Flow Growth (1y) (2022 - 2026)
Evotec SE (EVO) Net Cash Flow Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 112.26% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | -44.11% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -236.85% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | -1,047.81% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -1,020.00% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -807.00% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 444.33% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -107.45% |
| 10 | Evotec SE | 583.10 Mn | 582.58 Mn | - | -119.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -119.31% |
| Dec 31, 2025 | 163.54% |
| Sep 30, 2025 | -1,074.51% |
| Jun 30, 2025 | 94.72% |
| Mar 31, 2025 | 79.50% |
| Dec 31, 2024 | -323.77% |
| Sep 30, 2024 | -80.19% |
| Jun 30, 2024 | -895.94% |
| Mar 31, 2024 | -1,082.02% |
| Dec 31, 2023 | 137.83% |
| Sep 30, 2023 | 122.05% |
| Jun 30, 2023 | 0.45% |
| Mar 31, 2023 | 122.39% |
| Dec 31, 2022 | -185.41% |
| Sep 30, 2022 | -407.83% |
| Jun 30, 2022 | -83.01% |
| Mar 31, 2022 | -294.51% |